• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchErasca
    Picture of Erasca logo

    ERAS — Erasca News Story

    $14.870.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeLarge CapMomentum Trap
    • Market Cap
      $5.20bn
    • Enterprise Value
      $4.93bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • ERAS Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    ERAS Dividends
    All News

    NASDAQ RESUMED AT 03:47 PM

    Picture of Erasca logoErasca
    08/01/2026 20:47
    NASDAQ RESUMED  ERAS.O  AT 03:47 PM
    

    Recent news on Erasca

    See all news
    • Erasca, Inc. reports results for the quarter ended June 30 - Earnings Summary

      11/08/2026 21:41
    • Erasca Q2 net loss widens on higher R&D costs

      11/08/2026 21:13
    • Brief: Erasca Q2 Basic EPS USD -0.14

      11/08/2026 21:02
    • U.S. STOCKS ON THE MOVE-Bank of America, Analog Devices, Newmont

      14/07/2026 18:44
    • U.S. STOCKS ON THE MOVE-Bank of America, Analog Devices, Newmont

      14/07/2026 16:58

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.